CME
CME Group Inc
264.50$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +17.3% | +13.2% | +7.2% | +32.6% | +9.5% | +1.6% | -11.5% | +27.2% | +13.0% | +6.9% | +15.9% | |
| – | -2.0% | -1.4% | -7.5% | +19.3% | +90.3% | -1.9% | -17.0% | -5.9% | -2.8% | -4.5% | -1.8% | |
| – | +10.9% | +8.9% | -12.4% | +66.4% | -24.2% | +31.3% | -21.7% | +12.1% | -1.7% | +8.0% | +5.9% | |
| – | +48.3% | -120.6% | – | – | -33.8% | -27.6% | -635.2% | – | – | – | – | |
| – | – | – | – | – | -169.6% | – | -373.3% | – | – | – | – | |
| – | -18.8% | -19.6% | -10.8% | +42.5% | +110.5% | -19.6% | -35.6% | -29.5% | -14.8% | +23.0% | -11.2% | |
| – | – | +200.0% | +235.0% | -1,150.4% | -91.9% | +15.0% | – | -938.7% | – | -495.2% | – | |
| – | -10.2% | +33.0% | +11.5% | +7.8% | -21.1% | +24.4% | +3.8% | +20.3% | +22.9% | +10.8% | +9.7% | |
| – | -135.4% | +55.8% | +16.8% | +4,763.9% | – | -358.8% | – | -102.6% | -13.7% | +54.2% | +706.4% | |
| – | – | +83.9% | +761.1% | -2.7% | -160.7% | -54.0% | – | -131.9% | -99.9% | -100.0% | – | |
| – | -45.0% | +32.1% | +24.6% | -45.6% | +116.7% | +5.0% | – | -136.3% | +90.4% | – | +1,013.2% | |
| – | – | -46.1% | -80.1% | -1,610.9% | – | -54.3% | +88,263.2% | -131.5% | – | – | +617.2% | |
| – | +21.8% | +15.9% | +8.3% | +32.2% | +4.4% | +3.7% | -9.6% | +30.4% | +13.9% | +6.5% | +16.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.